SCOPUS BIOPHARMA INC. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/40089741-4395-4a55-b2b3-397722e78ed4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000666 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000947 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-043355 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001104659-21-043355 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SCOPUS BIOPHARMA INC. — all facts · Net Income · Operating Income